In this study, we utilized the GEPIA2 database and the packages “survival” and “survminer” to explore the correlation of CHMP4C expression levels with prognosis to determine whether CHMP4C can be regarded as a diagnostic biomarker for prostate cancer. Here, CHMP4C is linked to Familial prostate cancer.